Based on this idea, Qui et al. designed an injectable nanocomposite/hydrogel system (DOX/RAcNPs@GM gel) consisting of DOX, GM-CSF and imiquimod-loaded antigen-capturing NPs to actively recruit DCs, aiming to elicit a durable anti-tumor response. Here, CSF2 is linked to neoplasm.